Cellbricks
2 known investors
Cellbricks Therapeutics develops cell-based human tissue therapeutics using light-based biofabrication and AI-driven tissue engineering software to treat tissue dysfunction and organ failure. The company produces scalable, functional tissue implants designed to restore lost tissue and organ function for patients with no existing treatment options.